Emerging drugs in Tourette syndrome. - Wikidata - awgldk - TriplyDB

Emerging drugs in Tourette syndrome.

Emerging drugs in Tourette syndrome.

http://www.wikidata.org/entity/Q34423658

about

Tourette syndrome: evolving concepts.Intractable chronic motor tics dramatically respond to Clerodendrum inerme (L) Gaertn.

P2860

Q37864240-0EEA7F38-89FC-4CCC-8F07-637076A428B7 Q45925551-FB3E8AC4-0586-4EAA-8C4E-A2B54CC31EE2

P2860

Emerging drugs in Tourette syndrome.

http://www.wikidata.org/entity/Q34423658

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Emerging drugs in Tourette syndrome.

@ast

Emerging drugs in Tourette syndrome.

@en

Emerging drugs in Tourette syndrome.

@nl

type

label

Emerging drugs in Tourette syndrome.

@ast

Emerging drugs in Tourette syndrome.

@en

Emerging drugs in Tourette syndrome.

@nl

prefLabel

Emerging drugs in Tourette syndrome.

@ast

Emerging drugs in Tourette syndrome.

@en

Emerging drugs in Tourette syndrome.

@nl

P1433

Q34423658-85DCA4E8-3284-4F84-89A0-9BBDB9FC5108

P1476

Q34423658-6B4B0A2E-FA72-4279-BBF7-BD3F7EFDBD7C

P2093

Q34423658-B668D7D7-9B5A-4BEC-B4F5-2748A5179749

P2860

Q34423658-02D540DE-C183-4009-A8D3-F25C2FEF9223

Q34423658-04699E7E-567A-4DBC-A566-73F3308C5438

Q34423658-07793454-6883-4F06-A803-710CE6511879

Q34423658-0A25D796-2811-4B46-A5B0-2AE4631501AA

Q34423658-0A80E407-A642-4124-8009-377FA5416656

Q34423658-0C081F23-8477-42A3-8BD7-9D46DF9DDFD5

Q34423658-0FD2F47C-3664-4F9E-9EB6-8F9B31A4C1C4

Q34423658-16E96C0F-936C-4BD5-94B2-EB29D34FC2EB

Q34423658-171F4BA8-F4E1-48D2-818C-6212AAE2D5BB

Q34423658-187CCADE-84A1-4AF7-95FD-5A74065FD3A7

P304

Q34423658-FB344FEE-540A-45E1-A972-0074887010A6

P31

Q34423658-C979F017-498E-4A54-91C9-880DD48DC41B

P356

Q34423658-713668F8-D6FE-4101-BA43-78B7C072BD4C

P407

Q34423658-84B350ED-F7EA-4597-B89E-458B19B31EFE

P433

Q34423658-626BFDAA-7C62-4625-8088-3BA45E9E95B6

P478

Q34423658-3F390751-3722-43A5-910E-28DD2E82F533

P50

Q34423658-D7AB0739-04EB-47AA-8A91-B0B4881C85D9

P577

Q34423658-3C148889-A5E5-40BF-AAFB-BB994CC8BE70

P698

Q34423658-EA3EB470-A776-4E45-8EC7-9E19172C2CE8

P356

14728214.10.2.365

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging drugs in Tourette syndrome.

@en

P2093

Yavuz S Silay

http://www.w3.org/2001/XMLSchema#string

P2860

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.

Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome.

Tourette syndrome, associated conditions and the complexities of treatment.

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome.

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.

Quetiapine treatment of children and adolescents with Tourette's disorder.

Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome.

P304

365-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.10.2.365

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Jankovic

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15934872

http://www.w3.org/2001/XMLSchema#string